Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2021

Apr 30, 2021

34491_dirs_2021-04-30_18391ead-4f26-48b1-8731-84ee0ce86083.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2021-04-26

Reporting Person: List Alan (Chief Medical Officer)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (Right to Buy) $6.45 2030-10-26 Common Stock (100000) Direct

Footnotes

F1: The option vests in equal 6.25% installments at the end of each three-month period over a 48-month period beginning August 31, 2020.